Alliance Pharma (APH)

 

APH Share PerformanceMore

52 week high60.00 16/10/17
52 week low41.33 09/11/16
52 week change 13.00 (27.96%)
4 week volume12,449,303 24/09/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Alliance Pharma building international sales, says Hardman

Hardman Research has issued a report noting that Alliance Pharma's Kelo-cote brand is building international sales. Hardm...

Hardman Research: Kelo-cote international sales

RNS Number: 7998T Alliance Pharma PLC 17 October 2017 Hardman Research: Kelo-cote building international sales Kelo-cote building international sales - Alliance Pharma's buy-and-build strategy to evolve into a profitable, cash generative, specialty pharma business is bearing fruit. Acquisition of the dermatology and woundcare products from Sinclair Pharma ha...

Alliance Pharma revenues and earnings rise

Alliance Pharma's revenues rose by 8% to 50.3m in the six months to the end of June. EBITDA increased by 3% to 13.6m an...

Interim Results

RNS Number: 5694Q Alliance Pharma PLC 13 September 2017 For immediate release 13 September 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Interim Results for the six months ended 30 June 2017 Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, is pleased to announce its interim results for the six months ended 30 June ...

Appointment of Joint Corporate Broker

RNS Number: 9074P Alliance Pharma PLC 06 September 2017 For immediate release 6 September 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Appointment of Joint Corporate Broker Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, is pleased to announce the appointment of Investec Bank plc as joint corporate broker to ...

Notification of Interim Results

RNS Number: 6570M Alliance Pharma PLC 01 August 2017 For immediate release 1 August 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Notification of Interim Results Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, will announce its interim results for the six months ended 30 June 2017 on Wednesday 13 September 201...

Broker Forecast - finnCap issues a broker note on Alliance Pharma PLC

finnCap today reaffirms its buy investment rating on Alliance Pharma PLC (LON:APH) and cut its price target to 58p (fr...

Update on Diclectin

RNS Number: 4885M Alliance Pharma PLC 28 July 2017 For immediate release 28 July 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Update on Diclectin Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, announces that it has been advised by the UK's regulator, the Medicines and Healthcare products Regulatory Agency (M...

Fundamental DataMore

P/E ratio15.455
EPS3.85
Dividend yield2.034 %

Latest discussion posts More

  • Re: added

    Games - You will need to buy some more to catch up with me insofar as percentage of portfolio goes, I am at 10 percent. Cheers, ws
    17-Oct-2017
    winningstreak
  • added

    at 58.4 ---- 1.05% of my wad now. Games
    17-Oct-2017
    gamesinvestor
  • Re: H1 Results

    This is in my view a stock to buy and lock away. It is one of the few I feel wholly comfortable with, as I see no risk in the vicinity nor on the horizon. IMHO, WS
    17-Oct-2017
    winningstreak

Users' HoldingsMore

Users who hold Alliance Pharma also hold..
LLOYDS GRP.30%
NATIONAL GRID18%
GLAXOSMITHKLINE18%
BP16%
TESCO15%

Codes & Symbols

ISINGB0031030819
SymbolsAPH, LSE:APH, APH.L, APH:LN, LON:APH, XLON:APH